BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17242614)

  • 1. Trends in cost effectiveness analyses in orthopaedic surgery.
    Brauer CA; Neumann PJ; Rosen AB
    Clin Orthop Relat Res; 2007 Apr; 457():42-8. PubMed ID: 17242614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Introduction to methods of economic modelling: a primer for orthopaedic surgeons and traumatologists].
    Vavken P; Dorotka R
    Z Orthop Unfall; 2009; 147(4):419-23. PubMed ID: 19771671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costing and perspective in published cost-effectiveness analysis.
    Neumann PJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
    Gafni A; Birch S
    Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resource allocation in orthopaedics: economic evaluation to priority setting.
    Bate A; Donaldson C; Ray H
    Clin Orthop Relat Res; 2007 Apr; 457():49-56. PubMed ID: 17290157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalised cost-effectiveness analysis: an aid to decision making in health.
    Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
    Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Threshold values for cost-effectiveness ratio and public funding of medical technologies].
    Rabinovich M; Greenberg D; Shemer J
    Harefuah; 2007 Jun; 146(6):453-8, 500. PubMed ID: 17760400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of medical technologies.
    Seifan A; Shemer J
    Isr Med Assoc J; 2005 Feb; 7(2):67-70. PubMed ID: 15729952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
    Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
    Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conditions for introduction and financing of new technologies].
    Rutten FF; Grijseels EW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2229-32. PubMed ID: 10578419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Are the Strength of Recommendations and Methodologic Reporting in Health Economic Studies in Orthopaedic Surgery?
    Makhni EC; Steinhaus ME; Swart E; Bozic KJ
    Clin Orthop Relat Res; 2015 Oct; 473(10):3289-96. PubMed ID: 26024580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis for clinical procedures in oncology.
    Weinstein MC
    Bull Cancer; 1980; 67(5):491-500. PubMed ID: 6783150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.